Yes, tirzepatide use can result in bowel obstruction. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can slow gastrointestinal motility, which can cause food and bezoar formation to block your intestines.
Bowel obstruction can result in vomiting, nausea, and abdominal pain. If not treated, it can also result in the death of parts of the intestines. Severe cases will need surgical interventions, while less severe cases can be treated with bowel rest and medication.
Severe health conditions developed after at least one round of tirzepatide treatment might make you eligible for financial compensation. We encourage you to contact our experts at Atraxia Law for a thorough assessment of your claim. If you meet the eligibility criteria, we will refer you to a tirzepatide lawyer, who will file a claim on your behalf.